Clinical Trials Browser

Phase 2 × Recruiting × Castration Resistant Metastatic Prostate Cancer × Clear all

NCT04363164 2025-07-14

Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression

Phase 2 Recruiting

Castration Resistant Metastatic Prostate Cancer